North Brunswick, NJ, Rutgers Commercialization Center for Innovative Technology, April 17, 2018 – Dr. David M. Devilbiss, now Associate Professor, Cell Biology and Neuroscience, Rowan University, presented “Classification of concussion with …
3rd Cerora patent application accepted, 2nd in Australia patent office
Yardley, PA, April 16, 2018 – Cerora learned formally in writing from our patent counsel, Mike Dunnam, Esq., formerly BakerHostetler now at Schwegman, Lundberg, Woessner (Minneapolis, MN), that the company …
Cerora participates in Children’s Hospital of Philadelphia’s 6th Annual Minds Matter: Concussion Care for Kids Conference
Philadelphia, PA, Union League, April 12, 2018 – At the invitation of Graham Thomas, Co-Founder of the UNTOLD Foundation (www.theuntoldfoundation.org), Cerora CEO Adam Simon was invited to participate in the …
Cerora founder engages with Craig Venter scientifically at SUH Festival in San Francisco
San Francisco, CA, Tuesday, January 9, 2018 — Cerora CEO Adam Simon engages with Founder and CEO of Human Longevity Inc. Dr. Craig Venter scientifically after his panel discussion at …
Cerora presents its 25 year moonshot at the Startup Health Festival in San Francisco during JP Morgan healthcare week
San Francisco, CA, Monday January 8, 2018 — Cerora CEO Adam Simon presented the company’s ambitious moonshot to transform brain health assessment delivering peace of mind one biosensor at a …
Cerora presents its Borealis platform at Veterans Administration’s Brain Trust meeting at Harvard Medical School
Boston, May 18, 2017 — Cerora CEO Adam Simon presented Cerora Borealis in a curated invitation-only panel of new technology companies at the VA Brain Trust meeting at Harvard Medical …
Cerora accepted to participate in the RESI on MaRS 2017 Innovation Challenge on April 4 in Toronto
Cerora was accepted as one of the top applicants to participate in the Redefining Early Stage Investment (RESI) MaRS 2017 Innovation Challenge taking place in Toronto on Tuesday April 4th as …
Cerora patent application allowed in Australia patent office
Cerora learned from our IP counsel at BakerHostetler that they were successfully able to prosecute a second patent application to allowable matter, in this case before the Australian patent office. More …
Cerora presents on CNS Disease panel at TPP China Partnering event during JP Morgan
Cerora CEO Adam Simon presented the company’s Borealis(TM) technology briefly and discussed the state of the art of neurotechnology on a panel during the The Pharma Partners (TPP) China Partnering …
Cerora Presents at Cleveland Clinic Medical Innovation Summit
Cerora CEO Adam Simon presented the company’s Borealis(TM) technology to a packed audience before Vice President Joe Biden’s keynote address on the Cancer Moonshot. Cerora at 2016 Cleveland Clinic Medical …
- Page 1 of 2
- 1
- 2